or Try an Advanced Search...

    C1 Inhibitor Stocks List

    Symbol Grade Name % Change
    PHAR C Pharming Group N.V. -4.38
    KALV D KalVista Pharmaceuticals, Inc. 3.31
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Angioedema Complement Deficiency Hereditary Angioedema Pharmaceutical Acute Kidney Injury Biology Biopharmaceutical Products Complement System Diabetic Macular Edema Disease Drug Discovery Enzymes Eye Haemophilia Kallikrein Life Sciences Macular Edema Organ Systems Pharming Plasma Kallikrein

    Related ETFs - A few ETFs which own one or more of the above listed C1 Inhibitor stocks.

    Symbol Grade Name Weight
    QQQS A Invesco NASDAQ Future Gen 200 ETF 0.45
    IWC B iShares Microcap ETF 0.12
    XBI B SPDR S&P Biotech ETF 0.08
    VFMO B Vanguard U.S. Momentum Factor ETF 0.07
    IBBQ D Invesco Nasdaq Biotechnology ETF 0.05
    View all C1 Inhibitor ETFs...
    Compare ETFs
    Compare IWC to IBBQ Compare IWC to XBI Compare QQQS to IBBQ

        C1 Inhibitor Stocks Recent News

        Date Stock Title
        Oct 28 KALV KalVista Pharmaceuticals Presents New Sebetralstat Data at the 2024 American College of Allergy Asthma and Immunology
        Related Industries: Biotechnology
        Related Stock Lists: Angioedema Complement Deficiency Hereditary Angioedema Pharmaceutical Acute Kidney Injury Biology Biopharmaceutical Products Complement System Diabetic Macular Edema Disease Drug Discovery Enzymes Eye Haemophilia Kallikrein Life Sciences Macular Edema Organ Systems Pharming Plasma Kallikrein
        C1 Inhibitor

        C1 Inhibitor is a protein that helps regulate the activity of the complement system, which is part of the body's immune system. It helps to control inflammation and prevent the body from attacking itself. C1 Inhibitor is also used to treat certain types of hereditary angioedema, a condition that causes swelling in the face, throat, and other parts of the body.

        Browse All Tags